All lobbying filings

FERRING PHARMACEUTICALS, INC.

Lobbying for FERRING PHARMACEUTICALS, INC.

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate · $160,000.00 expenses · posted Oct 16, 2025

Official filing document

Bills named in this filing 7

HR 1670
Family Building FEHB Fairness Act
S 797
Family Building FEHB Fairness Act
HR 220
Veterans Infertility Treatment Act of 2025
S 2296
National Defense Authorization Act for Fiscal Year 2026
HR 3838
Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fiscal Year 20…
HR 1878
IVF Access and Affordability Act
HR 4639
Infertility Treatment Affordability Act of 2025

Lobbying activity 2

Health Issues

Issues related to fertility treatment and coverage (no bill); issues related to federal employee health care coverage (Family Building FEHB Fairness Act, H.R. 1670 / S. 797), issues related to veterans health coverage (Veterans Infertility Treatment Act, H.R. 220 / no Senate bill), issues related to infertility coverage for members of the military included in the National Defense Authorization Act (S. 2296, Sec. 705 / H.R. 3838, Sec. 703).

Taxation/Internal Revenue Code

Issues related to establishing a tax credit for fertility treatments (IVF Access and Affordability Act, H.R. 1878 / no Senate bill; Infertility Treatment Affordability Act, H.R.4639 / no Senate bill).

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.